15.7 (15.6) end stage kidney disease Flashcards
List THREE clinical scenarios in ESRD that results in the need for PC involvement
- those who choose or who are advised not to embark on dialysis (conservative mgmt)
- those who are failing to thrive on dialysis, experiencing worsening QOL and increasing symptom burden despite dialysis
- those who discontinue dialysis
What is the median survival after dialysis discontinuation (with what exception)
◆ 8-10 days
◆ If residual renal function, survival in months
Name TWO validated renal disease symptom assessment tools.
◆ Dialysis Symptom Index
◆ Renal version of the Patient Outcome Scale (symptom module)
◆ Integrated Patient Outcome Scale - Renal version (IPOS-Renal)
Non renal specific: ESAS
List FIVE symptoms commonly experienced by patients with ESRD
◆ anxiety & depression
◆ pain
◆ pruritus
◆ restless legs
◆ sleep disturbance
◆ fatigue
◆ other symptoms
- n/v
- drowsiness
- breathlessness
- leg edema
- dry mouth
- lack of appetite
- altered taste
- poor concentration
- dry skin
- constipation
◆ symptoms due to comorbid conditions
List THREE general causes of symptoms in patients with ESRD
◆ uremia
◆ dialysis
◆ comorbidity
List TWO opioids that can be safely used in ESRD
◆ fentanyl
◆ alfentanil
◆ buprenorphine
———–
◆ methadone
———–
Note on Hydromorphone: use carefully if mild or mod renal impairment (avoid in severe renal impairment)
List THREE causes of fatigue in ESRD
◆ Renal Disease
- anemia, hyperparathyroidism, uremia may contribute
◆ Dialysis
◆ Comorbid conditions
How to treat fatigue in ESRD?
◆Exercise and rehab
◆Treat anemia with erythropoietin stimulating agents (EPO)
What 1 metabolic derangement contribute to pruritus in ESRD and how to treat?
High PO4 - tx with phosphate binder and dietary advice
List FOUR systemic treatments for pruritus in ESRD
◆ Xerosis (dry skin) relieving agents
- emollients (dry skin)
◆ Immune modulators
- ultraviolet B light
- tacrolimus
- thalidomide
◆ Antihistamines
◆Neuropathic agents
- gabapentin
- capsaicin
◆ Opioid antagonists (limited use per uptodate)
- nalfurafine (Kappa agonist)
- butorphanol (Kappa agonist/mu antagionist)
◆ Anti-depressant (per uptodate)
List the FOUR diagnostic criteria for RLS
◆ urge to move legs, usually with unpleasant sensation
◆ worse during periods of rest or inactivity
◆ worse symptoms in evening or night
◆ partial or total relief by physical activity
List TWO drugs that can be used to manage RLS
List TWO non-pharmacological interventions to manage RLS
◆ Dopamine agonist (levodopa, ropinirole, pramipexole)
◆ Gabapentin
◆ Benzo (clonazepam)
◆ Avoid exacerbating agents (e.g. ETOH, caffeine, nicotine)
◆ Exercise
Note: huge change from 5th E. due to new systematic review (Sinclair, 2018)
List THREE drugs which may worsen RLS
Dopamine antagonist (e.g. maxeran)
Anti-depressants (e.g. SSRI, TCAs)
Anti-histamine
Lithium
FS:
Anti D
Anti H
Anti 5HT
Same meds that lower seizure threshold
List FOUR non-pharm approaches to managing dyspnea in ESRD
◆ sitting upright
◆ use of fan, stream of cool air
◆ calm, settled environment
◆ PT/OT (appropriate aids)
◆ mgmt of anxiety
◆ inhaled O2 if hypoxic
FS: think general SOB strategies
Breathlessness management
Self care
Equipment
Education, rehab, support group
Meds
Interventions (surgery, dialysis)
Under what conditions is active treatment with erythropoietin-stimulating agents likely to improve fatigue when anaemia is due to kidney disease?
◆ IF:
- glomerular filtration rate is less than 30 mL/min/1.73 m2 (<45 mL/min/1.73 m2 in diabetics)
- no other cause (such as blood loss, or folic acid or vitamin B12 deficiency) is identified
FS: GFR<30 ( <45 for diabetics)